Immunosuppressive Agents: all 5,940 studies that test it
Page 57 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Sirolimus in Treating Patients With Glioblastoma MultiformeCompletedNCT00047073Phase 1/2
- Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced CancerCompletedNCT00046904Phase 3
- Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone TherapyCompletedNCT00046826Phase 2
- Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS LymphomaCompletedNCT00045539Phase 2
- Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic LymphomaCompletedNCT00045513Phase 1/2
- Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00044954Phase 2
- Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant RecipientsCompletedNCT00044720Phase 4
- Daclizumab Injections to Treat Non-Infectious Sight-Threatening UveitisCompletedNCT00043667Phase 2
- Sirolimus for Focal Segmental GlomerulosclerosisCompletedNCT00040508Phase 2
- Daclizumab to Treat Wegener's GranulomatosisCompletedNCT00040248Phase 2
- Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation TherapyCompletedNCT00039468Phase 2
- CNI-1493 for Treatment of Moderate to Severe Crohn's DiseaseTerminatedNCT00038766Phase 2
- Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate CarcinomaCompletedNCT00038246Phase 1/2
- Thalidomide for Multiple MyelomaCompletedNCT00038233Phase 3
- Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select Patients With Locally Advanced Prostate CancerCompletedNCT00038181Phase 2
- Thalidomide-Dexamethasone for Multiple MyelomaCompletedNCT00038090Phase 2/3
- Study Evaluating Sirolimus (Rapamune™) in Solid Organ Transplant RecipientsCompletedNCT00037531Phase 3
- Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.WithdrawnNCT00037115Phase 4
- Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple SclerosisCompletedNCT00037102Phase 4
- Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid ArthritisCompletedNCT00036153Phase 3
- A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple SclerosisTerminatedNCT00035529Phase 2
- Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney DiseaseCompletedNCT00035308Phase 3
- A Pharmacokinetic Study to Determine the Oral Bioavailability of Methotrexate in Patients With Inflammatory Bowel DiseaseCompletedNCT00035074Not applicable
- Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or ThalassemiaTerminatedNCT00034528Phase 2
- The Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With EtanerceptCompletedNCT00034060Phase 2
- Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable LeiomyosarcomaStatus unknownNCT00033709Phase 2
- Combination Chemotherapy in Treating Women With Resected Breast CancerStatus unknownNCT00033683Phase 2
- Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple MyelomaCompletedNCT00033332Phase 3
- Radiation Therapy With or Without Thalidomide in Treating Patients With Brain MetastasesCompletedNCT00033254Phase 3
- Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic CancerCompletedNCT00031980Phase 2
- Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete RemissionCompletedNCT00031655Phase 2
- Increasing HAART-Induced Immune Restoration With CyclosporineCompletedNCT00031070Phase 2
- Thalidomide in Treating Anemia in Patients With Myelodysplastic SyndromeCompletedNCT00030550Phase 2
- Etanercept for Non-Infectious Lung Injury Following Bone Marrow TransplantationCompletedNCT00029328Phase 1/2
- Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple MyelomaStatus unknownNCT00028886Phase 3
- Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder UrotheliumCompletedNCT00028756Phase 3
- Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic CancerCompletedNCT00028730Phase 2
- Peripheral Stem Cell Transplant in Treating Patients With Multiple MyelomaCompletedNCT00028600Phase 2
- Study of Daclizumab in Patients With Chronic, Persistent AsthmaCompletedNCT00028288Phase 2
- Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Once Daily Versus Twice Daily DosingCompletedNCT00028171Not applicable
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00027924Phase 2
- Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerCompletedNCT00027820Phase 1/2
- Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney CancerStatus unknownNCT00027664Phase 2
- Thalidomide in Treating Patients With Metastatic Neuroendocrine TumorsCompletedNCT00027638Phase 2
- Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney CancerCompletedNCT00027573Phase 2
- Study of Muromonab-CD3 and Cyclosporine in Patients With Giant Cell MyocarditisCompletedNCT00027443Not applicable
- Thalidomide in Treating Patients With Thyroid CancerCompletedNCT00026533Phase 2
- Interferon Alfa and Thalidomide in Treating Patients With Stage IV MelanomaCompletedNCT00026520Phase 2
- Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone SarcomaStatus unknownNCT00026416Phase 2
- Thalidomide in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00025467Phase 2
- Combination Chemotherapy Plus Thalidomide in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00025285Phase 2
- Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the UterusCompletedNCT00025220Phase 2
- Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic LeukemiaCompletedNCT00025038Phase 2
- Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaCompletedNCT00024440Phase 3
- Steroid Withdrawal in Pediatric Kidney Transplant RecipientsTerminatedNCT00023244Phase 2
- Pediatric Kidney Transplant Without Calcineurin InhibitorsCompletedNCT00023231Not applicable
- Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00022607Phase 2
- Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaCompletedNCT00022581Phase 2
- Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of OriginStatus unknownNCT00022178Phase 3
- Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic LeukemiaCompletedNCT00022126Phase 2
- Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's MacroglobulinemiaCompletedNCT00020800Phase 2
- Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate CancerCompletedNCT00020046Phase 2
- UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or LeukemiaCompletedNCT00019838Phase 1
- Thalidomide in Treating Patients With HIV-Associated Kaposi's SarcomaCompletedNCT00019123Phase 2
- Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple SclerosisCompletedNCT00017628Phase 1
- Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic SyndromeCompletedNCT00017550Phase 2
- Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00017381Early Phase 1
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed NeuroblastomaCompletedNCT00017368Phase 2
- Thalidomide and SU5416 in Treating Patients With Metastatic MelanomaCompletedNCT00017316Phase 2
- Phase II Pilot Study of Cyclophosphamide and Rabbit Anti-Thymocyte Globulin as Salvage Therapy in Patients With Diffuse Systemic SclerosisCompletedNCT00016458Phase 2
- S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic SyndromeCompletedNCT00016419Phase 2
- Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast CancerTerminatedNCT00016276Phase 3
- Thalidomide in Treating Patients With Refractory or Resistant Epithelial Ovarian CancerCompletedNCT00016224Phase 2
- Thalidomide in Treating Patients With Myelodysplastic SyndromeCompletedNCT00015990Phase 2
- Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaTerminatedNCT00015912Phase 2
- Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic LeukemiaCompletedNCT00015873Phase 3
- Thalidomide in Treating Patients With MyelofibrosisCompletedNCT00015821Phase 2
- Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple SclerosisCompletedNCT00014755Phase 1
- Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain CancerCompletedNCT00014573Phase 2
- Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant GliomaTerminatedNCT00014443Phase 2
- Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the UrotheliumCompletedNCT00014274Phase 2/3
- Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic MalignanciesCompletedNCT00014235Not applicable
- The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid ArthritisStatus unknownNCT00012506Phase 3
- Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory PemphigusCompletedNCT00010413Phase 2
- Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody SyndromeCompletedNCT00010400Not applicable
- Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic DiseaseCompletedNCT00010387Phase 2
- Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Combination With Cyclosporine and Mycophenolate Mofetil in Patients With Inherited DisordersCompletedNCT00010361Not applicable
- Thalidomide With or Without Fludarabine in Treating Patients With Hematologic CancerTerminatedNCT00009984Phase 2
- Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's LymphomaStatus unknownNCT00009776Phase 1
- Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast CancerStatus unknownNCT00009763Phase 1
- Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow TransplantCompletedNCT00008450Phase 1
- Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple MyelomaCompletedNCT00008242Phase 2
- Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromesCompletedNCT00008177Phase 1
- Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT00008151Phase 2
- Adjuvant Stage 2-3A Breast Cancer With Positive Lymph NodesCompletedNCT00007904Phase 2
- Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid TumorsCompletedNCT00007813Phase 1
- Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaCompletedNCT00006890Phase 2
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell LymphomaCompletedNCT00006747Phase 2
- Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal TumorCompletedNCT00006734Phase 3
- Combination Chemotherapy Followed by Second-Look Surgery and Radiation Therapy in Treating Children With Nonmetastatic Medulloblastoma or Primitive Neuroectodermal TumorCompletedNCT00006461Phase 3